Trial · NCT00439777
Adverse events1,230
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,230
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Rivaroxaban (Xarelto, BAY59-7939) | 146 | 2,412 | |
| other | Constipation | Gastrointestinal disorders | Enoxaparin/VKA | 141 | 2,405 | |
| other | Diarrhoea | Gastrointestinal disorders | Rivaroxaban (Xarelto, BAY59-7939) | 128 | 2,412 | |
| other | Diarrhoea | Gastrointestinal disorders | Enoxaparin/VKA | 132 | 2,405 | |
| other | Nausea | Gastrointestinal disorders | Rivaroxaban (Xarelto, BAY59-7939) | 113 | 2,412 | |
| other | Nausea | Gastrointestinal disorders | Enoxaparin/VKA | 131 | 2,405 | |
| other | Chest pain | General disorders | Rivaroxaban (Xarelto, BAY59-7939) | 179 | 2,412 | |
| other | Chest pain | General disorders | Enoxaparin/VKA | 181 | 2,405 | |
| other | Nasopharyngitis | Infections and infestations | Rivaroxaban (Xarelto, BAY59-7939) | 188 | 2,412 | |
| other | Nasopharyngitis | Infections and infestations | Enoxaparin/VKA | 195 | 2,405 | |
| other | Contusion | Injury, poisoning and procedural complications | Rivaroxaban (Xarelto, BAY59-7939) | 95 | 2,412 | |
| other | Contusion | Injury, poisoning and procedural complications | Enoxaparin/VKA | 133 | 2,405 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Rivaroxaban (Xarelto, BAY59-7939) | 87 | 2,412 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Enoxaparin/VKA | 134 | 2,405 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Rivaroxaban (Xarelto, BAY59-7939) | 172 | 2,412 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Enoxaparin/VKA | 162 | 2,405 | |
| other | Headache | Nervous system disorders | Rivaroxaban (Xarelto, BAY59-7939) | 196 | 2,412 | |
| other | Headache | Nervous system disorders | Enoxaparin/VKA | 177 | 2,405 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Rivaroxaban (Xarelto, BAY59-7939) | 160 | 2,412 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Enoxaparin/VKA | 179 | 2,405 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00439777/events